<DOC>
	<DOCNO>NCT03012724</DOCNO>
	<brief_summary>The purpose study demonstrate efficacy safety deep brain rTMS , ( Transcranial Magnetic Stimulation ) H7-Coil treatment add treatment , good FDA clear , H1-Coil , subject major depressive disorder previously unsuccessfully treat antidepressant medication .</brief_summary>
	<brief_title>Efficacy H7-Coil DTMS Compared H1-Coil DTMS Subjects With Major Depression Disorder ( MDD )</brief_title>
	<detailed_description>This prospective , 6 week , double blind , randomize , control , multi-center trial . The study explore safety efficacy deep brain rTMS ( Transcranial Magnetic Stimulation ) H7-Coil treatment demonstrate good FDA clear , H1-Coil treatment add-on treatment antidepressant drug ( bi-therapeutic treatment ) subject major depressive disorder previously unsuccessfully treated antidepressant medication . Approximately 105 subject enrol study . The study population consist subject MDD fail adequate medication treatment current depressive episode . The patient racial , ethnic gender category , range 22 68 year age , HDRS-21â‰¥20 . Outpatients recruit academic private research center . The study duration 8 week , 2 week period screen baseline , follow 4 week 5 daily treatment 2 week biweekly treatment . Mood mental state carefully monitor standard psychological scale assessment screen baseline throughout treatment .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<criteria>Outpatients Men woman 2268 year age Primary DSMIV diagnosis Major Depression , single recurrent episode . Current depressive episode le 5 year duration The patient respond least one four antidepressant treatment current episode Patients complete antidepressant trial due intolerance therapy 2 antidepressant medication current episode Satisfactory safety screen questionnaire transcranial magnetic stimulation Patients suffer hypo hyperthyroidism base prestudy TSH level medically stabilize Capable willing provide inform consent able adhere treatment schedule Patient stable medication 2 month expect change medication study period Individuals diagnose Investigator follow condition ( current unless otherwise state ) : Depression secondary general medical condition , substanceinduced History substance abuse dependence within past 6 month ( except nicotine caffeine ) Any psychotic disorder ( lifetime ) , include schizoaffective disorder , major depression psychotic feature , Bipolar disorder , Eating disorder , Obsessive compulsive disorder Posttraumatic stress disorder ( current within past year ) Current generalize anxiety disorder , panic disorder social anxiety disorder Presence personality disorder ( antisocial , schizotypal , histrionic , borderline , narcissistic ) Individuals significant neurological disorder insult include , limited : Any condition likely associate increase intracranial pressure Space occupy brain lesion Any history seizure EXCEPT therapeutically induce ECT History cerebrovascular accident Transient ischemic attack within two year Cerebral aneurysm Dementia Mini Mental State Exam score less equal 24 Parkinson 's disease Huntington 's chorea Multiple sclerosis Increased risk seizure reason Individuals hearing loss ECT treatment within 3 month prior screen visit History treatment Vagus Nerve Stimulation ( VNS ) History treatment Deep Brain Stimulation ( DBS ) Use investigational drug within 4 week randomization visit Use prohibit study medication ( ) Present suicidal risk assess investigator significant suicide risk Any selfinflicted harm past 3 month context suicidal ideation Cardiac pacemaker , implanted medication pump , intracardiac line , acute , unstable cardiac disease Intracranial implant ( e.g. , aneurysm clip , shunt , stimulators , cochlear implant , electrode ) metal object within near head , exclude mouth , safely remove Implanted neurostimulators History abnormal MRI Known suspect pregnancy If participate psychotherapy , must stable treatment least 3 month prior entry study , anticipation change frequency therapeutic session , therapeutic focus duration rTMS trial Clinically significant laboratory abnormality , opinion Investigator base CBC biochemistry Women childbearing potential use medically accept form contraception engage sexual intercourse Women : pregnant , plan become pregnant , currently nurse</criteria>
	<gender>All</gender>
	<minimum_age>22 Years</minimum_age>
	<maximum_age>68 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>TMS</keyword>
	<keyword>Deep Transcranial Magnetic Stimulation</keyword>
	<keyword>MDD</keyword>
	<keyword>Major Depressive Disorder</keyword>
</DOC>